Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05530590
Other study ID # STUDY00014177
Secondary ID 5R01AG075734
Status Recruiting
Phase N/A
First received
Last updated
Start date January 31, 2024
Est. completion date July 4, 2026

Study information

Verified date June 2024
Source University of Minnesota
Contact Simon Rosser, PhD,MPH
Phone 612-624-0358
Email rosser@umn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.


Description:

The study involves conducting a 3-arm, stratified (management/staff), group (agency) randomized controlled trial (RCT) of the in-person vs. online intervention vs. waitlist control on organizational factors (i.e., environment and policy) and on staff knowledge, attitudes, and skills.


Recruitment information / eligibility

Status Recruiting
Enrollment 760
Est. completion date July 4, 2026
Est. primary completion date April 21, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - licensure in Minnesota to provide nursing and/or as a housing with services establishment - Willingness to undertake a policy and environment review at baseline and 6 months later - having at least 5 managers/ supervisors and 5 staff. Exclusion Criteria: - Participants who cannot speak and read English

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Training to Serve (TTS) in person training
Participants receive in person training.
Training to Serve online training (eTTS)
Participants receive online training.

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (2)

Lead Sponsor Collaborator
University of Minnesota National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Discrimination experience at work Adapted everyday discrimination scale Baseline
Other Discrimination experience at work Adapted everyday discrimination scale immediately post-intervention
Other Discrimination experience at work Adapted everyday discrimination scale 6 months post-intervention
Other Social desirability at work Marlowe Crowne Social desirability scale Baseline
Other Social desirability at work Marlowe Crowne Social desirability scale immediately post-intervention
Other Social desirability at work Marlowe Crowne Social desirability scale 6 months post-intervention
Other Sexual and Religious Identification Duke Religiosity Index Baseline
Other Sexual and Religious Identification Duke Religiosity Index 6 months follow-up post-intervention
Other Agency demographics Agency type, size and staff Baseline
Other SGM estimate Number of SGM staff Baseline and 6 month follow up.
Other SGM estimate Number of SGM staff 6 months follow up post-intervention
Primary Environment change Access to sexual and gender minority (SGM) providers, gender neutral intake forms baseline and 6-months follow up
Primary Skills assessment Ability to conduct 7 skills key to providing competent care to SGM Baseline
Primary Skills assessment Ability to conduct 7 skills key to providing competent care to SGM Immediately post-intervention
Primary Competence in SGM Care Competent scale when it comes to providing care to SGM 6 months after intervention
Secondary SGM with AD/ADRD referenced explicitly in policies Human Resources policies and intake forms Baseline
Secondary SGM with AD/ADRD referenced explicitly in policies HR policies and intake forms 6 months post-intervention
Secondary SGM knowledge 10-item review of key content in training Baseline
Secondary SGM knowledge 10-item review of key content in training immediately post-intervention
Secondary SGM knowledge 10-item review of key content in training 6 months post-intervention
Secondary SGM attitudes Homonegativity scale Baseline
Secondary SGM attitudes Homonegativity scale immediately post-intervention
Secondary SGM attitudes Homonegativity scale 6 months post-intervention
Secondary Health care empathy Jefferson Physician Empathy student version Baseline
Secondary Health care empathy Jefferson Physician Empathy student version immediately post-intervention
Secondary Health care empathy Jefferson Physician Empathy student version 6 months post-intervention
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A